BIOGEN INC.
Develops innovative therapies for complex neurological and neurodegenerative conditions.
BIIB | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 225 BINNEY STREET, 2142 CAMBRIDGE
- Website:
- https://www.biogen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Biogen Inc. is a global biotechnology company founded in 1978. It engages in discovering, developing, and delivering innovative therapies for complex and devastating diseases, with a primary focus on neurological and neurodegenerative conditions. The company pioneers scientific research to create new medicines and biosimilars aimed at transforming patients' lives. Biogen's portfolio is centered on treatments for various neurological disorders, reflecting its commitment to addressing significant unmet medical needs through science and innovation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIOGEN INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIOGEN INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
